Air Q Laryngeal Airway Versus the AmbuAura Gain as a Conduit for Endotracheal Intubation

NCT ID: NCT05607433

Last Updated: 2022-11-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

44 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-11-30

Study Completion Date

2022-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aims to compare the efficacy of the Ambu AuraGain to that of the Air Q ILA as a conduit for endotracheal intubation assisted by tube exchanger. The comparison will be in terms of total intubation time, success rate of insertion of the tube exchanger as well as endotracheal intubation and complications.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Very few studies discussed assisted endotrachealc intubation using certain tools as bougie through the Air Q ILA .

the hypothesis in this study is that the use of flexible, small calibre tube exchanger introduced through both supraglottic devices into the trachea as guidance for endotracheal intubation, will have shorter intubation time with the Ambu AuraGain than the Air Q ILA and less complications in both devices.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Difficult Intubation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized comparative study
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Participants
only participants will be masked

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Air Q ILA group

Air Q supraglottic device will be placed in the participants in this group .

Group Type EXPERIMENTAL

cook ®Airway Exchanger Catheter

Intervention Type DEVICE

A tube exchanger is a small calibre , flexible tube used to guide endotracheal intubation through a supraglottic device.

Ambu AuraGain group

Ambu AuraGain supraglottic device will be placed in the participants in this group .

Group Type EXPERIMENTAL

cook ®Airway Exchanger Catheter

Intervention Type DEVICE

A tube exchanger is a small calibre , flexible tube used to guide endotracheal intubation through a supraglottic device.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

cook ®Airway Exchanger Catheter

A tube exchanger is a small calibre , flexible tube used to guide endotracheal intubation through a supraglottic device.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age : 18 to 60
* ASA physical status 1 and 2
* body weight less than 90 kilos
* Ganzouri airway score less than or equal to 3.

Exclusion Criteria

* Active respiratory or cardiac disease
* Any expected airway difficulties
* Craniofacial abnormalities or fractures
* patients with abnormal coagulation profile
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cairo University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hoda Zakaria Saleh Hassan Alrify

assistant lecturer of anesthesia

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kasr Alainy Hospital

Cairo, Elmanial, Egypt

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Hoda Alrify

Role: CONTACT

002 01004226722

References

Explore related publications, articles, or registry entries linked to this study.

Karim YM, Swanson DE. Comparison of blind tracheal intubation through the intubating laryngeal mask airway (LMA Fastrach) and the Air-Q. Anaesthesia. 2011 Mar;66(3):185-90. doi: 10.1111/j.1365-2044.2011.06625.x.

Reference Type BACKGROUND
PMID: 21320087 (View on PubMed)

Bakker EJ, Valkenburg M, Galvin EM. Pilot study of the air-Q intubating laryngeal airway in clinical use. Anaesth Intensive Care. 2010 Mar;38(2):346-8. doi: 10.1177/0310057X1003800217.

Reference Type BACKGROUND
PMID: 20369770 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

supraglottic devices

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.